Council of Economic Advisers Wades into Drug Pricing Conversation

On February 9, 2018, the Council of Economic Advisers released a report looking at drug pricing proposals entitled “Reforming Biopharmaceutical Pricing at Home and Abroad.” The report highlights two goals: reducing the price that Americans pay for biopharmaceutical products and raising innovation incentives as a way to reduce the overall price of health in the […]